Avaxia Biologics

About:

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.

Website: http://www.avaxiabiologics.com

Top Investors: AbbVie, Golden Seeds, Tech Coast Angels, LaunchPad Venture, Cherrystone Angel Group

Description:

Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts.

Total Funding Amount:

$35.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)avaxiabiologics.com

Founders:

Barbara S. Fox, David Poorvin

Number of Employees:

11-50

Last Funding Date:

2014-12-01

IPO Status:

Private

Industries: